Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	17.61B
Revenue (ttm)	11.55B
Net Income (ttm)	1.04B
Shares Out	1.16B
EPS (ttm)	0.89
PE Ratio	17.07
Forward PE	13.92
Dividend	0.36 (2.34%)
Ex-Dividend Date	May 22, 2025

Volume	17,212,475
Average Volume	11,189,801
Open	14.36
Previous Close	14.81
Day's Range	14.36 - 15.28
52-Week Range	12.96 - 18.96
Beta	0.42
RSI	68.59
Earnings Date	Aug 20, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.